Introduction
Phosphatidylserine (PS) exposure in platelets is a physiological response required for normal haemostasis (1) . The PS exposure mechanism depends on a lipid scramblase, which has been shown to be stimulated by Ca 2+ influx mediated by a Ca 2+ -ionophore in platelets and erythrocytes (2) (3) (4) . PS exposure is also a hallmark of apoptosis and appears to be a fundamental mechanism by which apoptotic cells are recognized and eliminated by phagocytic macrophages (5) . As a matter of fact, platelet apoptosis has been shown in different models, including aging during storage, associated to mitochondrial membrane depolarization and caspase 3 activation (6-7). Caspases have been investigated in Ca 2+ -ionophore stimulated platelets and results have accompanied by depolarization of the mitochondrial membrane, cytochrome c release, calpain-processing of caspases 9 and 3 to active enzymes, as well as a prolonged increase in both cytosolic and mitochondrial Ca 2+ concentrations. In contrast, in the absence of extracellular Ca 2+ , the Ca 2+ -ionophore A23187 induced a smaller transient increase in both cytosolic and mitochondrial Ca 2+ concentrations, but did not induce any other phenomena, nor phosphatidylserine exposure. However, phosphatidylserine exposure and depolarization induced by dibucaine still occurred in spite of inhibition of intracellular Ca 2+ elevation. Thus we conclude that phosphatidylserine exposure in platelets is associated with mitochondrial apoptotic-like events. Therefore, we propose that mitochondria engagement in an apoptotic pathway in platelets could lead to PS exposure without the participation of Ca 2+ .
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Summary
Phosphatidylserine exposure in platelets is required for normal haemostasis and is also a hallmark of apoptosis. It results from activation of a phospholipid scramblase, which has been shown to be differently stimulated by Ca 2+ -influx and during apoptosis, thus suggesting that mitochondria may be involved in phosphatidylserine exposure in platelets. It is also well known that local anaesthetics can expose phosphatidylserine in platelets and affect the mitochondrial metabolism in other cells. Thus, the present study was undertaken to evaluate the specific involvement of mitochondria in phosphatidylserine exposure in platelets. For this purpose, we stimulated phosphatidylserine exposure by local anaesthetics and avoided any external Ca 2+ -influx by performing all experiments in the absence of added Ca 2+ . We report that phosphatidylserine exposure, induced by the lipophilic local anaesthetics dibucaine and tetracaine, was shown that caspases 9 and 3 are processed in a calpain-dependent manner to an inactivated form at 30 kDa (8), while caspase 3 was shown to be activated in a subset of platelets stimulated by thrombin and collagen (9) .
Activation of a scramblase has been shown to be required to initiate loss of membrane asymmetry in apoptosis (10) . This enzyme has also been characterized in lymphoid cells and results showed that it functions independently of Ca 2+ in apoptotic cells (11) . This raises the possibility that the scramblase may be activated independently of a Ca 2+ influx, and depending on apoptosis. It is now recognized that mitochondria play a key role in apoptosis. This lead us to propose as a working hypothesis that mitochondrial apoptotic-like events could be implicated in PS exposure in platelets.
In an attempt to address this issue, we have used local anaesthetics which have been shown to expose PS in platelets (12, 13) and also to induce apoptosis in nucleated cells through caspase activation and cytochrome c release (14, 15) . Other effects of local anaesthetics included inhibition of oxygen consumption in cells (16) , decrease or even collapse of the transmembrane potential of mitochondria (∆Ψ) in living cells (17) (18) (19) , their action on the Ca 2+ regulating systems within the cell (20) , and finally their postulated action on the membrane bilayer (21, 22) .
We report that PS exposure, induced by the lipophilic local anaesthetics dibucaine and tetracaine, in the absence of extracellular Ca 2+ , was accompanied by collapse of the membrane potential, cytochrome c release, calpain-processing of caspase 3 to an active enzyme. Significantly, in the absence of extracellular Ca 2+ , the Ca 2+ -ionophore A23187 did not induce any of these effects, nor did it expose PS. Thus PS exposure associated with apoptotic-like mitochondrial events, can occur independently of Ca 2+ in platelets.
Materials and methods

Materials
Dibucaine, lidocaine, tetracaine and rhodamine 123 were purchased from Sigma Chemical Co (St. Louis, MO). Fluo-3-AM was from Molecular Probes (Eugene, OR). Dithionite was from Aldrich (Strasbourg, France). 1-oleoyl-2-[12-(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-sn-glycero-3phospho-serine (sodium salt) (NBD-PS) was from Avanti Polar Lipids, Inc (Alabaster, AL, USA). B27D8, a monoclonal antibody for the catalytic subunit of calpain was provided by Dr. T. Kunicki (Scripps Research Institute, La Jolla, CA). E64d, BAPTA-AM and DEVD-CHO were from Biomol (Tebu, Le Perray-enYveline, France). The polyclonal rabbit anti-caspase 3 antibody (# 65906E) was from Pharmingen (Becton Dickinson, Le Pont de Claix, France) and the monoclonal mouse anti-caspase 9 antibody (Ab-2) from Oncogene (Calbiochem, La Jolla, CA). These antibodies recognize both the native and catalytic form of the caspases. PhiPhiLux-G 1 D 2 was from Alexis (Coger, Paris, France). Peroxidase-labelled affinity-purified second antibodies specific for the F(ab') 2 fragment of mouse IgG were from Jackson Immunoresearch Laboratories (West Grove, PA). The chemiluminescence-based Western blot detection system ECL Plus was from Amersham Corp. (Buckinghamshire, UK).
Platelet isolation
Freshly drawn blood (usually 10 ml) was obtained from control subjects by venepuncture using acid-citrate-dextrose formula A as anticoagulant and platelets were isolated as already described (13) . Platelets were resuspended at 1 ϫ 10 8 /ml in 137 mM NaCl, 2 mM KCl, 0.5 mM NaH 2 PO 4 , 0.5 mM MgCl 2 , 10 mM Hepes, and 5.5 mM glucose, pH 7.4 containing 0.1 mM EGTA (reaction buffer).
Fluorescence imaging of mitochondria in platelets using rhodamine 123
We used the vital fluorescent probe rhodamine 123 to monitor the mitochondrial transmembrane potential in platelets (23) . Platelets were incubated in reaction buffer with 2.5 µM rhodamine 123 (from a 125 µΜ stock solution in ethanol) for 15 min at 37°C, pelletted and washed once in the presence of 2 mM EDTA, then resuspended in reaction buffer at 5 ϫ 10 7 /ml. They were layered onto a plate coated with 2% gelatine. Plated coverslips were mounted in an Attofluor chamber (Atto Instruments Inc.) and maintained at 37°C on the microscope stage using a Climacell 2.22 controller unit (Cultimat Technologies). The cells were imaged using a Zeiss Axiovert 100 M inverted microscope fitted with a 100 W Mercury light source (Zeiss) 95% attenuated by neutral density filters (Omega Optical), and a Zeiss 63ϫ (N.A 1.40) Plan Apochromat objective. Signals were acquired using computerized shutter and filter wheels (Sutter Instruments) at excitation and emission ports piloted through a Lambda 10-2 controller (Sutter Instruments). Filter combination for rhodamine 123 imaging was: 490DF20 excitation, 535DF25 emission, and a 400-477-575 TBDR dichroic mirror (Omega Optical). Images were acquired at 1 Hz with a Micromax 1300Y 5 MHz cooled CCD camera (Princeton Instruments), using MetaMorph 4.5 (Universal Imaging Corporation) for both imaging and analysis.
Flow cytometric assay for mitochondrial membrane potential using rhodamine 123 Platelets (5 ϫ 10 7 /ml) were incubated in reaction buffer for 30 min at 37°C with 1 µM rhodamine 123, washed once in the presence of EDTA, and then incubated for one hour at 37°C with 2 mM lidocaine, 2 mM tetracaine, or 1 mM dibucaine (from stock solutions of 250 mM in water), diluted ten fold and analysed in the flow cytometer.
In some studies, 100 µM BAPTA-AM was co-incubated with rhodamine 123 to study the effect of Ca 2+ chelation on ∆Ψ.
Flow cytometric assay for aminophospholipid exposure using NBD-PS as a reporter
The fluorescence assay using dithionite reduction of NBD-PS was based on the work of McIntyre & Sleight (24) . Washed platelets were incubated for 30 min at 37°C with 1 µM NBD-PS from a stock solution of 1 mM in water-free ethanol. After one wash in reaction buffer containing 2 mM EDTA, they were resuspended at 5 ϫ 10 7 /ml in reaction buffer and incubated with 2 mM lidocaine, 2 mM tetracaine, or 1 mM dibucaine for one hour at 37°C. Platelets were diluted 5-fold and analysed in the flow cytometer. Then 5 mM dithionite from a freshly made 1 M stock solution in 1 M Tris-base pH 10 was added to each of the samples, the reduction reaction of NBD-PS exposed to the aqueous phase was allowed to proceed for 3 min and the samples were re-analysed in the flow cytometer.
In some studies, 100 µM BAPTA-AM or 50 µM DEVD-CHO were co-incubated with NBD-PS to study the effect of Ca 2+ chelation or caspase 3 inhibition on PS exposure.
Flow cytometric studies of caspase 3 activation using the cell-permeable substrate PhiPhiLux-G 1 D 2 Platelets were incubated with the local anaesthetics at 5 ϫ 10 7 /ml in 250 µl reaction buffer for 30 min. Then 50 µl were withdrawn and mixed with 10 µl of 10 µM PhiPhiLux-G 1 D 2 substrate solution and the mixture was incubated for another 30 min, as recommended by the manufacturer to obtain efficient hydrolysis. The samples were diluted 5-fold and immediately analysed in the flow cytometer.
Cytochrome c release
After incubation for one hour at 37°C with the local anaesthetics, platelet samples were permeabilized with 1 µM digitonin for 1 min at 4°C and centrifuged at 4°C for 5 min at full speed in an Eppendorf centrifuge. The pellets were solubilized with 50 µl 1X Laemmli reducing buffer. After 16% SDS-PAGE and Western blotting, membranes were probed with a mouse monoclonal anti-cytochrome c antibody (Zymed). Membranes were stripped and reprobed with a rabbit polyclonal anti-MnSOD antibody (StressGen).
Western blotting
Platelets were incubated with the local anaesthetics at 37°C for one hour, the reaction was stopped by adding 10X Laemmli reducing buffer and samples were boiled for 10 min. In some samples, platelets were preincubated with 0.150 mM E64d or with 50 µM DEVD-CHO for 30 min before the local anaesthetics were added. After electrophoresis on 12% (w/v) SDS-polyacrylamide gels in a Mini-PROTEAN II Electrophoresis Cell (BioRad), proteins were electrophoretically transferred onto nitrocellulose membrane for 1 h at 100 V using the Trans-Blot Electrophoretic Transfer Cell, and the membranes were treated as usual. 
where K d is the dissociation constant for the Ca 2+ -dye (800 and 500 nM respectively for fluo 3 and rhod 2) and F is the fluorescence of the sample. The calibration procedure consisted of obtaining first F max by lysing platelets with 0.1% Triton X-100 in the presence of 2 mM added Ca 2+ , and F min by adding 4 mM EGTA from a 0.5 M EGTA stock solution in 3 M Tris pH 8.3, 0.15 M NaCl.
In some studies, 100 µM BAPTA-AM was co-incubated with fluo 3-AM or rhod 2-AM to evaluate the effect of Ca 2+ chelation on both cytosolic and mitochondrial free Ca 2+ concentration.
Apparatus
Platelets were analysed in a FACScan flow cytometer or FACScalibur (Becton Dickinson). Gating was performed as already described (13) and 10,000 particles were acquired and analysed for forward (FSC) and right-angle light scatter (SSC), as well as for fluorescence (F). The light scatter and fluorescence signals were set in logarithmic gain. Fluorescence emission was monitored using a 530/30 band pass filter for FITC.
Fluorescence mesurements were performed in a Spex FluoroMax fluorimeter (Spex Industries Inc., Edison, NJ) equiped with a thermostatic jacket and a stirring device.
Results
Flow cytometric studies of the effect of local anaesthetics on the mitochondrial membrane potential in platelets To establish that local anaesthetics affect mitochondrial membrane potential (∆Ψ) in platelets, we used a flow cytometric method on platelets stained with the mitochondrial probe rhodamine 123. Results show a decrease in the mean fluorescence intensity of rhodamine 123-labelled platelets incubated in the presence of the hydrophobic local anaesthetics dibucaine and tetracaine ( Fig. 1A and B, light histogram) compared to unstimulated platelets (bold histogram), indicating a decrease in ∆Ψ. In contrast, the less hydrophobic local anaesthetics, lidocaine produced no effect (Fig.1C) .
To exclude the possibility of a cytosolic distribution of rhodamine 123 in platelets, we examined fluorescence images of rhodamine 123-loaded platelets by digitized fluorescence microscopy. Results showed a punctiform labelling of the cells, suggesting that the dye accumulates selectively in mitochondria (Fig. 1, bottom) , depending on the negatively charged membrane potential across the inner mitochondrial membrane.
Evidence that local anaesthetics induce PS exposure in the absence of extracellular Ca 2+ As the effect of local anaesthetics on ∆Ψ did not depend on extracellular Ca 2+ , we checked whether PS exposure occurred in platelets preincubated with the local anaesthetics in the absence of Ca 2+ . As the use of annexin V was precluded due to its absolute requirement for Ca 2+ , transbilayer PS movement to the cell surface was studied by dithionite reduction of NBD-PS exposed to the aqueous phase, resulting in the extinction of the fluorescence. The inner membrane leaflet was loaded with NBD-PS, and platelets were incubated with the local anaesthetics and their fluorescence was measured by flow cytometry before ( Fig. 2A-2D ) and after dithionite addition ( Fig. 2A'-2D') . The fluorescence of platelets labelled with NBD-PS and treated with dibucaine ( Fig. 2B) and tetracaine (Fig. 2C ) decreased when dithionite was added (Fig. 2B' and 2C' ), indicating that PS was the reaction allowed to proceed for 3 min, and the samples reanalysed in the flow cytometer (A' to D').The platelet population outside the circle, with decreased fluorescence in the presence of dithionite, had exposed PS. Control (A and A'), dibucaine (B and B'), tetracaine (C and C'), and lidocaine (D and D').
exposed to the outer leaflet of the plasma membrane. When the less hydrophobic lidocaine was used, the fluorescence of the whole platelet population did not change (Fig. 2D and D' ) as in controls ( Fig. 2A and A') , showing that they did not expose PS.
Effect of local anaesthetics on caspase 3 and 9 processing and correlation with calpain activation As loss of mitochondrial membrane potential leads to apoptosis with caspase activation, we studied caspase 3 and 9 activation by Western blotting in platelets incubated with the local anaesthetics in the absence of extracellular Ca 2+ .
Results showed that pro-caspase 3, detected as a band around 32 kDa in control unstimulated platelets (Fig. 3A, left,  lane 1) , decreased in intensity in platelets incubated with dibucaine and tetracaine (lanes 2 and 3), but not with lidocaine (lane 4). In addition to a decrease in the caspase 3 labelling intensity at 32 kDa, a new band was frequently observed at 30 kDa. This is illustrated during a kinetic study of caspase 3 activation in platelets treated with tetracaine, which clearly showed a time-dependent appearance of the 30 kDa band. In addition, two other hydrolytic products were observed around 20 kDa, one of which may correspond to the 17 kDa active form of caspase 3 (Fig. 3A, right) .
In parallel to caspase 3, we also studied caspase 9 activation in platelets. Results showed that the labelling of pro-caspase 9 at 45 kDa in untreated platelets (Fig. 3B, left, lane 1) decreased in platelets incubated with dibucaine and tetracaine (Fig. 3B, left, lanes 2 and 3) and two bands appeared at about 37 and 35 kDa, while lidocaine had no effect (Fig. 3B, left, lane 4) .
To study the relationship between caspase 3 processing and calpain activity which is still a matter of debate (8-9), calpain was analysed by stripping and reprobing the blots with an anticalpain monoclonal antibody. In platelets incubated with dibucaine and tetracaine, but not lidocaine, results showed a decrease in calpain labelling with the appearance of small hydrolytic products (Fig. 3B, right) . When platelets were incubated with the calpain inhibitor E64d, calpain activation was inhibited (Fig. 3C, right) and neither caspase 3 (Fig. 3C , left) nor caspase 9 (result not shown) processing occurred. These results demonstrate a correlation between caspase 3 and 9 processing and calpain activation. However, PS is still exposed in the presence of calpain inhibitor (result not shown). Moreover, platelets pre-incubated in the presence of DEVD-CHO, a membrane-permeable caspase 3 inhibitor, and then with dibucaine can still expose PS (result not shown), although caspase 3 processing is inhibited (compare lanes 2 and 3 in Fig. 4) . Interestingly, caspase 3 processing is also inhibited by DEVD-CHO for platelets stimulated with the Ca 2+ -ionophore in the presence of 2 mM Ca 2+ (lane 4). This result rules out the participation of caspase 3 processing in PS exposure in platelets.
Flow cytometric study of caspase 3 activity using PhiPhiLux-G 1 D 2 To determine whether caspase 3 hydrolysed products at about 20 kDa were associated with hydrolytic activity, a flow cytometric study was performed using PhiPhiLux-G 1 D 2 , a membrane-permeable fluorescent substrate for caspase 3 that increases in fluorescence when hydrolysed by caspase 3. Results showed that platelets loaded with PhiPhiLux-G 1 D 2 (bold histograms in Fig. 5 ), as defined in the dot plot of sideversus forward-angle light scatter for control non-activated platelets (13), exhibited a higher fluorescence when exposed to dibucaine and tetracaine (Fig. 5A , 5B, light histograms) while lidocaine had no effect (Fig. 5C ). The inability of lidocaine to induce caspase 3 ( Fig. 3) and PhiPhiLux-G 1 D 2 proteolysis is in favour of the specificity of this result. This suggests that, in the time course of procaspase 3 processing in platelets pre-loaded with PhiPhilux-G 1 D 2 , incubation with dibucaine and tetracaine activates caspase 3, which hydrolyses the substrate.
Effect of local anaesthetics on cytochrome c release
As cytochrome c release is one of the hallmarks of apoptosis, we investigated whether local anaesthetics induced cytochrome c release in platelets. Because under our experimental conditions, platelet fractionation always leads to some unavoidable platelet lysis and cytochrome c release in the supernatant for control samples, we chose to detect cytochrome c depletion in the mitochondria. Therefore cytochrome c was analysed in the mitochondria-containing pellet. Results showed the total absence and lower level of cytochrome c in pellets of platelets treated with dibucaine or tetracaine, respectively ( Fig. 6 lanes 2  and 3 ). In contrast, the level of cytochrome c was similar in control (lane 1) and lidocaine samples (lanes 4). To confirm that equivalent amounts of mitochondrial proteins were loaded in each lane, blots were stripped and immunoblotted with an antibody to MnSOD, a mitochondrial matrix protein (Fig. 6 , bottom). 
Effect of local anaesthetics on cytosolic and mitochondrial Ca 2+ levels in platelets
To assess the contribution of intracellular Ca 2+ to these processes, we measured [Ca 2+ ] c and [Ca 2+ ] m in platelets labelled with fluo 3-AM and rhod 2-AM, respectively, and incubated with dibucaine or lidocaine in the absence of extracellular Ca 2+ . Basal [Ca 2+ ] was 18.4 +/-7.1 (n = 15) nM in mitochondria and 256 +/-75 (n = 10) nM in the cytosol. Dibucaine increased both cytosolic and mitochondrial [Ca 2+ ] while lidocaine induced no effect (Fig. 7) . The Ca 2+ uptake into mitochondria was biphasic, as was the increase in cytosolic [Ca 2+ ], with an initial rapid rise, followed by a slower, sustained increase. Both Ca 2+ signals processed with apparently the same kinetics. We have also measured changes in cytosolic and mitochondrial free [Ca 2+ ] in platelets incubated with the Ca 2+ -ionophore, in the absence of extracellular Ca 2+ . In contrast to the preceding Ca 2+ signals, we found a different kinetics, with an initial rapid rise which peaked to 60 and 1000 nM, respectively, for mitochondrial and cytosolic free [Ca 2+ ], followed by a decrease in both signals.
Effect of chelation of intracellular free Ca 2+ on PS exposure and ∆ ∆Ψ Ψ To check whether the intracellular Ca 2+ increase induced by dibucaine can be responsible for scramblase activation even in the absence of a Ca 2+ influx, and for collapse of ∆Ψ, we incubated platelets with BAPTA-AM, a membrane-permeable Ca 2+ chelator. Figure 8 shows that the intracellular presence of BAPTA-AM drastically reduced both cytosolic and mitochondrial Ca 2+ increase for dibucaine-and A23187-stimulated platelets. However, PS are still exposed and ∆Ψ is still collapsed for platelets incubated with dibucaine (results not shown). This result showed that dibucaine-induced intracellular Ca 2+ signals are not responsible for PS exposure and ∆Ψ collapse.
Discussion
In order to define the mitochondrial events involved in PS exposure in platelets, we used local anaesthetics known to affect mitochondrial metabolism in a variety of cells (14, 15) . To avoid any stimulation of the phospholipid scramblase by Ca 2+ -influx, experiments were performed in the absence of added extracellu- lar Ca 2+ and in the presence of 0.1 mM EGTA. Thus a prerequisite for this study was to show that local anaesthetics could induce PS exposure in platelets without extracellular Ca 2+ , as this platelet response had usually been studied in the presence of Ca 2+ . The fluorescence assay using NBD-PS as a probe for PS exposure clearly showed that hydrophobic local anaesthetics, such as dibucaine and tetracaine, were capable of inducing PS exposure without added Ca 2+ (Fig. 2) , validating their use as tools for studying mechanisms dependent on mitochondria and independent of Ca 2+ -influx. Then, we studied several specific parameters of the mitochondrial metabolism. It had been previously shown that hydrophobic local anaesthetics inhibited mitochondrial respiration and collapsed the ∆Ψ (16-19, 26 ). Thus we examined the effect of local anaesthetics on ∆Ψ and found, as expected, that only the hydrophobic anaesthetics dibucaine and tetracaine induced mitochondrial ∆Ψ collapse (Fig. 1) . Both mitochondrial ∆Ψ collapse and PS exposure indicated that apoptotic-like events could be implicated. Therefore we studied cytochrome c release and caspase 3 and 9 activation. Our results showed that hydrophobic local anaesthetics released mitochondrial cytochrome c in platelets (Fig. 6) . We also demonstrated caspase 3 and 9 proteolysis and their dependence on calpain activation (Fig. 3) . However, a new finding in our study is that we clearly detected caspase 3 processing in platelets incubated with tetracaine accompanied by the appearance of the active form at 17 kDa (Fig. 3A right) . The caspase 3 activity was confirmed by hydrolysis of PhiPhiLux-G 1 D 2 , a caspase 3 substrate (Fig. 5 ). This contrasts with previous results, showing calpaininduced proteolysis of caspase 3 in Ca 2+ -ionophore A23187-treated platelets (9) and neuroblastoma cells (27) in the presence of Ca 2+ , leading to an inactive enzyme. This result can be due to a different mode of processing of caspase 3 due to massive Ca 2+ influx induced by the Ca 2+ -ionophore.
However, the correlation between calpain and caspase activation excludes the participation of the latter in PS exposure, as calpain inhibition did not inhibit PS exposure, as shown in previous studies with local anaesthetics in the presence of Ca 2+ (13) , but also without Ca 2+ and in the presence of caspase 3 inhibitor (Fig. 4) .
Thus, although the experiments reported in this study have been performed in the absence of extracellular Ca 2+ , one hypothesis is that local anaesthetics can induce cytosolic Ca 2+ increase which stimulates directly scramblase. Therefore, we studied Ca 2+ concentration changes in both cytosol and mitochondria, as the latter compartiment is implicated in cellular Ca 2+ homeostasis (28) . Our results showed that dibucaine increased cytosolic Ca 2+ concentrations (Fig. 7 left) while lidocaine did not (Fig. 7 middle) . The mechanisms involved could be Ca 2+ displacement by local anaesthetics from binding sites on membranes (29) , increased efflux of Ca 2+ from the endoplasmic reticulum pool (20, 30) , coupled with inhibition of Ca 2+ reuptake by the endoplasmic reticulum, as shown for bupivacaine, another local anaesthetics (31) . Concomittant with this increase in the cytosolic Ca 2+ concentration, our results showed a sustained Ca 2+ increase in mitochondria to about 200 nM (Fig. 7  left) . Moreover, Ca 2+ is not released from mitochondria, this inhibition of Ca 2+ efflux has already been shown with nupercaine, another local anaesthetics (32) (33) . As a comparison, we studied the effect of the Ca 2+ -ionophore A23187 in the absence of extracellular Ca 2+ , and found no PS exposure, change in ∆Ψ, or cytochrome c release (data not shown). Concerning internal Ca 2+ , we observed a fast initial increase followed by a decrease in both cytoplasmic and mitochondrial Ca 2+ signals (Fig. 7  right) . In the latter case, the mechanism involved may be Ca 2+ release from internal stores and its uptake into mitochondria, followed by Ca 2+ extrusion from mitochondria and re-sequestration of cytosolic Ca 2+ in the endoplasmic reticulum stores, due to the activity of platelet SERCA-pumps. This contrasts with the effects observed with local anaesthetics. Therefore, the sustained cytosolic Ca 2+ increase coupled with mitochondrial Ca 2+ overload may be required for PS exposure and collapse of ∆Ψ. Thus we have studied PS exposure and ∆Ψ in platelets which have been loaded with BAPTA-AM, a Ca 2+ chelator, before their incubation with dibucaine. Results showed that PS exposure and ∆Ψ collapse still occurred, in spite of a drastic reduction in both cytosolic and mitochondrial Ca 2+ concentration elevations (Fig. 8) . This result rules out the possibility that the scramblase is stimulated by intracellular Ca 2+ discharge, and also that collapse of ∆Ψ could be due to mitochondrial Ca 2+ overload.
Thus, we have shown that PS exposure in platelets can occur independently of Ca 2+ . Whether the Ca 2+ -independant molecular mechanisms associated to or downstream the mitochondrial apoptotic-like events reported in this study involve stimulation of the same or a different scramblase remains to be evaluated. A part from Ca 2+ , the scramblase can be activated at pH<6 (34), a situation found in apoptosis since cytosolic pH acidification occurs (35) , and also as the result of local anaesthetics which are acidtropic agents (36) . The scramblase has also been shown to be regulated by phosphorylation by PKC δ translocated to the plasma membrane in apoptosis (37) , and this may be another Ca 2+ -independent mechanism for scramblase activation. Another mechanism linked to apoptosis could be cytochrome c-induced oxidative attack of PS, as already proposed, thus leading to its spontaneous and/or scramblase-assisted externalisation (38) .
It could be very significant that PS exposure is associated to mitochondrial apoptotic-like events without the requirement for Ca 2+ . This may explain that Scott syndrome platelets, characterized by a Ca 2+ -induced defective PS exposure, has been shown to expose PS in the presence of tetracaine (39) . As a confirmation, the scramblase in lymphoid cells from a patient with the Scott syndrome cannot be activated by Ca 2+ , but is induced normally during apoptosis (11) . However, as already discussed in our previous paper (39) , spontaneous PS exposure as the result of membrane bilayer perturbation due to high concentration of local anaesthetics, cannot be excluded (21, 22) .
In certain conditions, local anaesthetics are responsible for cardiac and cerebral toxicity (40) , through accidental intravenous injection. Therefore, blood cells can externalise PS, which is a signal for their elimination, in addition to increased adhesion to vascular endothelium (41, 42) and to acceleration of the coagulation cascade (43, 44) .
